Vext Science Q3 net loss widens 86% to USD 4.88 million; Q3 revenue rises 18% to USD 14.9 million

Bitget2026/11/03 11:52

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Vext Science's third-quarter 2026 net loss widened 86% year over year to USD 4.88 million.
Revenue climbed 18% year over year to USD 14.9 million.
Net cash provided by operating activities fell 39% year over year to USD 5.16 million for the nine months ended September 30.
In October, the company listed its Phoenix manufacturing property for sale and began reducing Arizona manufacturing to packaging for its own dispensaries.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vext Science Inc. published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03